BioSpace News Archive

Business

Collaborative Clinical Study Aims to Advance Treatment of Kidney and Prostate Cancer with 3D Printing

Stratasys announced a new clinical study is being conducted with the New York University (NYU) School of Medicine – aimed at advancing diagnosis and treatment of complex kidney and prostate tumors through imaging and 3D printing.

October 23, 2017

·

5 min read

Deals

Spero Therapeutics Launches Initial Public Offering

Spero has also granted the underwriters a 30-day option to purchase an additional 750,000 shares of its common stock.

October 23, 2017

·

3 min read

Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Chemotherapy, ARS, Genetic Disorders and Autoimmune Diseases

Patent significantly expands potential indications for PLX-R18 and grants Pluristem broad coverage in the treatment of damaged hematopoietic systems.

October 23, 2017

·

5 min read

Pharming Announces Warrant Exercises and Conversions of Its Ordinary Bonds Into Shares Mostly Through Cashless Exercise

Pharming Group N.V. announced that since the release of its update regarding cashless and other warrant exercises and bond conversions on 10 August 2017.

October 23, 2017

·

5 min read

Biotech Bay

Natus to be Exclusive U.S. Agent for the First Neonatal MRI Device

The Embrace Neonatal MRI System is designed specifically for imaging of the neonatal head.

October 23, 2017

·

2 min read

Novo Nordisk: Share Repurchase Programme

Under the programme initiated 9 August 2017, Novo Nordisk will repurchase B shares for an amount up to DKK 3.9 billion in the period from 9 August 2017 to 30 October 2017.

October 23, 2017

·

1 min read

Business

Vical Reports Third Quarter 2017 Financial and Operational Results

Vical had cash and investments of $35.2 million at September 30, 2017.

October 23, 2017

·

7 min read

ADC Therapeutics Announces Closing of $200 Million Private Financing to Fund Two Lead Programs Through Registrational Trials

ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced that it has raised $200 million through a private placement.

October 23, 2017

·

2 min read

Business

Kraig Biocraft Laboratories New Biotechnology Research and Production Center is Now Operational

The new facility will expand Kraig Labs’ research and production programs.

October 23, 2017

·

2 min read

Drug Development

TiGenix Granted Orphan Drug Designation From the U.S. FDA for Cx601

TiGenix NV announces that the FDA has granted orphan drug designation (ODD) to Cx601 for the treatment of patients with fistulizing Crohn´s disease.

October 23, 2017

·

4 min read